Table 1 Clinical characteristics of the patients recruited for proteomics analysis
Number | Age range (year) | CA125 (0.00–35.00 U/ml) | HE (40–81.9 pmol/L) | Prothrombin time (11–14.5 s) | CRP (0.0-5 mg/L) | Histopathology | FIGO stage |
|---|---|---|---|---|---|---|---|
1 | 43–72 | 120.1 | 365.9 | 12.4 | 4.6 | HGSC | IIIC |
2 | 43–72 | 103.7 | 160.4 | 12.7 | NA | HGSC | IIIC |
3 | 43–72 | 39.08 | 94.96 | 13 | NA | HGSC | IIIA |
4 | 43–72 | > 5000 | 1400 | 12.7 | NA | HGSC | IIIC |
5 | 43–72 | 239.6 | > 1500 | 13.6 | NA | HGSC | IIIC |
6 | 43–72 | 188.3 | 499.3 | 12.3 | NA | HGSC | IIIC |
7 | 43–72 | 1104 | 590.3 | 12.8 | NA | HGSC | IV |
8 | 43–72 | 70.63 | 55.35 | 13 | NA | HGSC | IIIC |
9 | 43–72 | 422.3 | 102 | 12.7 | NA | HGSC | IIIC |
10 | 43–72 | 381 | 52.09 | 12.8 | NA | HGSC | IIIC |